Sagimet Biosciences expands board to 9, appoints Jennifer Jarrett and Dr. Anne Phillips as directors

Sagimet Biosciences Inc.

Board expanded from 7 to 9 directors; appointments effective August 1, 2024.
Jennifer Jarrett, COO of Arcus Biosciences, joins Audit Committee; Dr. Anne Phillips, former Novo Nordisk SVP, joins Nominating & Governance Committee.
Each new director receives initial stock option grant of $300,000 vesting over 3 years under 2023 Stock Option Plan.
Both are independent under Nasdaq rules; no related party transactions disclosed.
Jarrett serves on boards of Syndax, Zura Bio, others; Phillips on boards of Trevena, Barinthus, vTv Therapeutics.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Anne Phillips

Director

SGMT · Sagimet Biosciences Inc.

Effective: 2024-08-01
Filed: August 1, 2024, 7:59 PM ET

the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024

Appointed

Jennifer Jarrett

Director

SGMT · Sagimet Biosciences Inc.

Effective: 2024-08-01
Filed: August 1, 2024, 7:59 PM ET

the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Anne Phillips was appointed as Director at Sagimet Biosciences Inc..

Action: appointed
Role: Director

Exact text from the filing

the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer Jarrett was appointed as Director at Sagimet Biosciences Inc..

Action: appointed
Role: Director

Exact text from the filing

the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024

View on SEC.gov

Sagimet Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-084645

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.